Elsevier

Brain Research

Volume 841, Issues 1–2, 11 September 1999, Pages 135-142
Brain Research

Research report
Dopamine receptor-modulated [35S]GTPγS binding in striatum of 6-hydroxydopamine-lesioned rats

https://doi.org/10.1016/S0006-8993(99)01812-0Get rights and content

Abstract

The role of dopamine receptor–G protein coupling in the development of striatal dopamine receptor supersensitivity was studied in rats with a 6-hydroxydopamine (6-OHDA)-induced unilateral lesion of the nigrostriatal pathway. This coupling was assessed by the measurement of dopamine agonist-induced guanosine 5′-O-(γ[35S]thio)triphosphate ([35S]GTPγS) binding in striatal membranes, at different periods of time (1–5 weeks) following the microinjection of the neurotoxin. From the first to the fifth week following the lesion, basal and dopamine-stimulated [35S]GTPγS-specific binding were found to be enhanced in the denervated striata as compared to their control counterpart. D2 dopamine receptors were clearly demonstrated to be involved in this supersensitivity, as assessed by measuring N-propylnorapomorphine (NPA)-, quinpirole- and bromocriptine-induced [35S]GTPγS-specific binding. The involvement of D1 dopamine receptors was indirectly studied by the combination of dopamine with a saturating concentration of the selective and potent D2 antagonist domperidone. In these conditions, the remaining response to dopamine was also found to be significantly increased following the lesion. These results are consistent with the hypothesis that, in addition to D2 dopamine receptor upregulation, modulation of dopamine receptor–G protein interaction is involved in the hypersensitivity accompanying striatal dopamine depletion.

Introduction

Neurotransmitter receptors are subject to various forms of regulation that allow their physiological responses to be modified appropriately in response to changes in the environmental conditions. Such mechanisms affecting dopamine receptors have been implicated in the appearance of motor disorders arising after chronic neuroleptic treatment or in Parkinson's disease. Indeed, these two situations led to a dramatic decrease in the stimulation of dopamine receptors within the nigrostriatal pathway. Although there is a large body of work describing the regulation of dopamine receptors (for review, see Ref. [29]), the functional consequences at the biochemical level are not fully understood.

Experimentally, alteration in the dopamine transmission can be obtained after intranigral microinjection of 6-hydroxydopamine (6-OHDA), that results in dopamine depletion in the corresponding striatum. In this well-known model of hemi-Parkinsonism [33], the density of striatal D2 dopamine receptors is generally found to be increased 1, 8. This is accompanied by enhanced functional responses to dopamine agonists, as measured by behavioural [34], electrophysiological [14]and biochemical 9, 22techniques. It is, however, noteworthy that the time course and the amplitude of changes in dopamine receptors density were not clearly found to be consistent with those of hypersensitivity to dopamine agonists 23, 30. Moreover, in several models of dopaminergic hypersensitivity, an increase in functional response is not always correlated with D2 dopamine receptor upregulation [17]. In particular, rats with a unilateral 6-OHDA lesion chronically treated with eticlopride rotate contralateral to the lesion in response to quinpirole despite showing striatal symmetry of D2 receptor binding [16]. Concerning the D1 dopamine receptor density after dopamine depletion, the results described in the literature are conflicting (for review, see Ref. [29]), with most of the data indicating a decrease in D1 receptor expression. Some authors have proposed that modulation at the level of the signal transduction could explain the dopaminergic hypersensitivity following dopamine depletion or chronic dopamine receptor blockade. Thus, changes in striatal G-protein densities or functions have been proposed to be involved in the enhancement of the functional responses to dopamine agonists 4, 5, 20, 28, 31, 32.

The aim of our study was to evaluate the role played by the modulation of dopamine receptor–G protein coupling in the development of dopaminergic hypersensitivity accompanying the unilateral nigral 6-OHDA lesion. For this purpose, we compared dopamine agonist-induced binding of guanosine 5′-O-(γ[35S]thio)triphosphate ([35S]GTPγS) in membranes of denervated and control striata from the same animals. Agonist-induced binding of non-hydrolysable analogues of GTP was proven to be useful to study the functional coupling of a large variety of G protein-coupled receptors, in different models of transfected cells as well as in tissues 18, 19, 35. This technique was previously optimised for the study of dopamine receptor–G protein coupling in membranes of rat striatum 11, 27.

In order to take more than one stage of the pathological state into account, the analysis was performed after different periods of time (1–5 weeks) following the lesion. Indeed, most data from the literature focus on a single time interval after the lesion resulting in some conflicting observations. Together, our results show that dopamine-stimulated [35S]GTPγS-specific binding was increased following the lesion as compared to the contralateral striata. Pharmacological characterization of the response to dopamine revealed the involvement of both D1 and D2 dopamine receptors. A preliminary report of some of these data has been presented at the XIIIth International Congress of Pharmacology [10].

Section snippets

Surgery

Under chloral hydrate anaesthesia (400 mg/kg), male Wistar rats (250–300 g) were placed in a David Kopf stereotaxic frame. A unilateral injection of 6-OHDA (4 μl of a 3 mg/ml solution of 6-OHDA hydrobromide in 0.9% NaCl and 0.1% sodium metabisulfite) was delivered into the substantia nigra pars compacta at stereotaxic coordinates measured from bregma: lat=−1.8 mm; post=−5.2 mm; prof=−7.8 mm [25]. Theoretical coordinates were previously adjusted by stereotaxic microinjection of India ink in the

Characterization of dopamine receptor-mediated [35S]GTPγS binding

As previously reported [11], the specific binding of [35S]GTPγS to rat striatal membranes was found to be increased in the presence of dopamine. Thus, dopamine increased the [35S]GTPγS binding by up to ∼50% after 60 min incubation. Indeed, both basal and dopamine-induced specific binding of [35S]GTPγS progressively increased during the incubation, but their ratio was found to be relatively constant between 15 and 60 min (not shown). To a lesser extend (∼30% above basal), the effect of dopamine

Discussion

The aim of the present work was to evaluate alteration in the functional coupling of dopamine receptors in rat striatum after prolonged dopamine depletion within the nigrostriatal pathway. Dopamine receptor agonist-modulation of [35S]GTPγS binding was measured in order to study the first step in the signalling pathway activated by dopamine receptors. We have previously reported the optimization of experimental conditions of this assay for the characterization of the pharmacological properties

Acknowledgements

The authors wish to thank A. Lebbe and H. Lenaert for their excellent technical assistance and Dr. C. Godfraind (from the Laboratory of Special Pathological Anatomy of the Catholic University of Louvain) for her help in adjusting histologically accurate stereotaxic coordinates. This work was supported by the National Fund for Scientific Research (F.N.R.S., Belgium, Convention FRSM 3.453.997F), by a Grant of Ministry of Scientific Policy (Belgium) (ARC 95/00-188), and by the Belgian Queen

References (36)

Cited by (23)

  • Novel antiviral activity of bromocriptine against dengue virus replication

    2016, Antiviral Research
    Citation Excerpt :

    Since dengue fever is a human disease, we further investigated the anti-DENV-1 property of BRC in human A549, Huh7, and 293T cells and confirmed its antiviral activity in these cells without cytotoxicity (Fig. S2). Because BRC has been reported to be an agonist of dopamine receptors 2 and 3 (Geurts et al., 1999; Perachon et al., 1999; Velasco and Luchsinger, 1998), whether the agonistic activity was associated with the antiviral effect was then examined. Unexpectedly, quinpirole (mainly D2 receptor agonist (Fernandez-Duenas et al., 2012)) and rotigotine (mainly D3 receptor agonist (Scheller et al., 2009)) did not suppress DENV-1 replication (Fig. 1D).

  • Molecular Mechanisms of L-DOPA-Induced Dyskinesia

    2010, Handbook of Behavioral Neuroscience
    Citation Excerpt :

    The G-protein coupling efficiency of striatal DA receptors has been studied in both rats and monkey models of PD by measuring DA agonist-induced guanosine 5’-O-(gamma[35S]thio)triphosphate ([35S]GTP-gammaS) binding. These studies have shown that agonist-induced G protein-binding activity is increased at both D2- and D1-type receptors following a DA denervating lesion (Geurts et al., 1999; Aubert et al., 2005), and that enhanced G protein-coupling activity of D1 receptors is particularly important to LID (Aubert et al., 2005). Indeed, a comprehensive study performed in MPTP-intoxicated and l-DOPA-treated monkeys has revealed a positive linear relationship between D1 agonist-induced GTP binding activity in the striatum and dyskinesia severity scores (Aubert et al., 2005).

  • Maladaptive striatal plasticity in l-DOPA-induced dyskinesia

    2010, Progress in Brain Research
    Citation Excerpt :

    The G-protein-coupling efficiency of striatal DA receptors has been studied in both rat and monkey models of PD by measuring DA agonist-induced guanosine 5′-O-(gamma[35S]thio)triphosphate ([35S]GTP-gammaS) binding. These studies have shown that DA denervating lesions result in increased agonist-induced G-protein-binding activity at both D2- and D1-type receptors (Aubert et al., 2005; Cai et al., 2002; Geurts et al., 1999) and that the G-protein-coupling activity of D1, but not D2 receptors, is further enhanced in LID (Aubert et al., 2005). The increased guanosine triphosphate (GTP)-binding activity of D1 receptors is paralleled by an upregulation of Gα-olf proteins (Corvol et al., 2004; Herve et al., 1993) and by a pronounced overactivity of the D1 receptor-adenylyl cyclase signal transduction pathway (Mishra et al., 1974; Pifl et al., 1992).

  • Evaluation of the antipsychotic effect of bi-acetylated l-stepholidine (l-SPD-A), a novel dopamine and serotonin receptor dual ligand

    2009, Schizophrenia Research
    Citation Excerpt :

    The test session consisted of 20 trials. Brain membrane fractions were obtained as previously reported (Geurts et al., 1999; Panchalingam and Undie, 2000). Briefly, one day after the behavioral test, rats were sacrificed by decapitation.

  • Altered expression of regulators of G-protein signaling (RGS) mRNAs in the striatum of rats undergoing dopamine depletion

    2003, Biochemical Pharmacology
    Citation Excerpt :

    Depending on the RGS protein species examined, both positive and negative modulations of their genetic expression were observed in the 6-hydroxydopamine lesion model, whereas a general decrease was observed after the repeated administration of reserpine. Unilateral lesion of the dopamine nigrostriatal pathway by stereotaxic microinjection of 6-hydroxydopamine in the substantia nigra was performed as described previously [27]. A pre-treatment with 25 mg/kg desipramine and 5 mg/kg pargyline, 30 min prior to surgery, was demonstrated to enhance both the selectivity and amplitude of the destruction of dopaminergic neurons [28,29].

View all citing articles on Scopus
View full text